PGC-1α expression in VHL-deficient ccRCC cells restores mitochondrial function, upregulated antioxidant gene expression, suppresses tumor growth, and sensitizes cancer cells to cytotoxic chemotherapy and radiotherapy treatments [69]. This evidence concerns the gene PPARGC1A and nonpapillary renal cell carcinoma.